CONCLUSIONES
A pesar del gran arsenal medicamentoso antidepresivo que disponemos, sólo unos pocos tienen buena afinidad por provocar sedación y respetar las fases del sueño, a pesar de ello hemos descrito aquellos que tienen buena sedación pero no respetan las fases propias en cuanto a calidad del sueño y viceversa, pero se siguen empleando debido a su alto poder sedativo, por ello, hemos querido aportar una breve revisión para que sirva de apoyo a aquellos profesionales que no terminen de comprender bien su utilidad terapéutica.
BIBLIOGRAFÍA
– Kupfer DJ, Perel JM, Pollock BG, Nathan S, Grochocinski VJ, Wilson MJ, et al. Fluvoxamine vs desipramine: comparative polysomnographic effects. Biol Psychiatry 1991;29:23-40. –
– Kupfer D, Ehlers D, Pollock B, Nathan S, Perel J. Clomipramine and EEG sleep in depression. Psychiatry Res 1989;30:165-80.
– Passouant P, Cadhilac J, Billiard M. Withdrawal of the paradoxical sleep by the clomipramine, electrophysiological, histochemical and biochemical study. Int J Neurol 1975;10:186-97.
– Kupfer DJ, Hanin I, Coble P, Spicker DG, Sorisio D, Grau TG. EEG sleep and tricyclic blood levels: acute and crhonic administration in depression. J Clin Pharmacol 1982;2:8-13. – Höchli D, Riemann D, Zulley J, Berger M. Initial REM sleep supression by clomipramine: a prognostic tool for treatment response in patients with major depressive disorder. Biol Psychiatry 1986;21:1217-20. – Sharpley AL, Cowen PJ. Effect of pharmacological treatments on the sleep of depressed patients. Biol Psychiatry 1995;37:85-98. – Shipley JE, Kupfer DJ, Griffin SJ, Dealy RS, Coble PA, McEachran AB, et al. Comparison of effects of desipramine and amitryptiline on EGG sleep of depressed patients. Psychopharmacology 1985;85:14-22.
– Bardeleben UV, Steiger A, Gerken A, Holsboer F. Effects of fluoxetine upon pharmacoendocrine and sleep-EEG parameters in normal controls. Int Clin Psychopharmacol 1989;4:1-5. – Kupfer DJ, Hanin I, Spicker DG, Neil J, Coble P. EEG sleep and tricyclic plasma levels in primary depression. Commun Psychopharmacol 1979;3:73-80.
– Kupfer DJ, Ehlers CL, Frank E, Grochocinski VJ, Buhari A. Persistent effects of antidepressants: EEG sleep studies in depressed patients during maintenence treatment. Biol Psychiatry 1994;35:781-93. – Vasar V, Appelberg B, Rimón R, Selvaratnam J. The effect of fluoxetine on sleep: a longitudinal, double-blind polysomnographic study on healthy subjects. Int Clin Psychopharmacol 1994;9:203-6.
– Mendlewicz J, Kempenaers C, Mawrtelaer V. Sleep EEG and amitryptiline treatment in depressed patients. Biol Psychiatry 1991;30:691-702. – Feinberg I, Floyd TC, March JD. Effects of sleep loss on delta (0.3-3 Hz) EEG and eye movement density: new observations and hypotesis. Electroencephalogr Clin Neurophysiol 1986;67:217-21.
– Bramanti P, Bianchi L, Benedetto M, Ricci RM, Scribano MA, Di Perri R. Study of the hypnic effect of amineptine evaluation by means of polygraphy and tests. Prog Neuropsychopharmacol Biol Psychiatry 1985;9: 157-65. – Yamadera H, Nakamura S, Suzuki H, Endo S. Effects of trazodone hydroclhoride and imipramine on polysomnography in healthy subjects. Psychiatry Clin Neurosci 1998;52:439-43.
– Di Perri R, Mailland F, Bramanti P. The effects of amineptine on the mood and nocturnal sleep on depressed patients. Prog Neuropsychopharmacol Psychiatry 1986;11:65-70.
– Mouret J, Lemoine P, Minuit M, Sánchez P, Taillard J. Sleep polygraphic effects of trimipramine in depressed patients. Drugs 1989;38:14-6.
– Akindale MO, Evans JI, Oswald I. Monoamineoxidase inhibitors, sleep and mood. Electroencephalogr Clin Neurophysiol 1970;29:47-56.
– Schenck CH, Mahowald MW, Kim SW, O’Connor KA, Hurwitz TD. Prominent eye movements during NREM sleep and REM sleep behavior disorder associated with fluoxetine treatment of depression and obsesive-compulsive disorder. Sleep 1992;15:226-35.
– Hoff P, Golling H, Kaphammer R, Lund R, Pakesh E, Ruether E, et al. Cimoxaton and moclobemid, two new MAO-inhibitors: influence on sleep parameters in patients with major depressive disorders. Pharmacopsychiatry 1986;19:249-50.
– Mendelewicz J, Dunbar GC, Hoffman G. Changes in sleep EEG architecture during the treatment of depressed patients with mianserin. Acta Psychiatr Scand 1985;72(Suppl 320):26-9.
– Nicholson AN, Pascoe PA. Studies on the modulation of the sleep-wakefulness continuum in man by fluoxetine, a 5-HT uptake inhibitor. Neuropharmacology 1988;27:597-602.
– Cipaparelli A, Dani A, Gemignani A, Guazzelli M. The effects of fluoxetine on sleep pattern: a clinical and all-night EEG study in patients with major depression. J Sleep Res 1992;1:41.
– Sharpley AL, Walsh AE.S, Cowen PW. Nefazodone-a novel antidepressant may increase REM sleep. Biol Psychiatry 1992;31:1070-3.
– Brunello N, Armitage R, Feinberg I, Holsboer-Trachsler E, Léger D, Linkowski P, et al. Depression and sleep disorders: clinical relevance, economic burden and pharmacoligical treatment. Neuropsychobiology 2000;42:107-19.
– Saletu B, Frey R, Kruphka M, Anderer P, Gruenberger J, See W. Sleep laboratory studies on the single-dose effects of serotonin reuptake inhibitors paroxetine and fluoxetine on human sleep and awakening qualities. Sleep 1991;14:439-47.
– Tormey WP, Buckley MP, O’Kelly DA, Conboy J, Pinder RM, Darragh A. Sleep endocrine profile of the antidepressant mianserin. Curr Med Res Opin 1980;6:456-60. – Ruigt GS, Kemp B, Groenhout CM, Kamphuisen HA. Effect of the antidepressant Org 3770 on human sleep. Eur J Clin Pharmacology 1990;38:551-4.
– Armitage R, Rush AJ, Trivedi M, Cain J, Roffwarg H. The effects of nefazodone on sleep architecture in depression. Neuropsychopharmacology 1994;10:123-7.
– Sharpley AL, Williamson DJ, Attenburrow ME.J, Pearson G, Sargent P, Cowen PJ. The effects of paroxetine and nefazodone on sleep: a placebo controlled trial. Psychopharmacology 1996;126:50-4.
– Mouret J, Lemoine P, Minuit MP, Benkelfat C, Renardet M. Effects of trazodone on the sleep of depressed subjects: a polygraphic study. Psychopharmacology 1998;95(Suppl):S37-43.
– Besset A, Brissaud E, Senegas E, Billiard M. Effects of buspirone on night sleep architecture and daytime performance. Sleep Res 1987;16:75. – Vogel G, Cohen J, Mullis D, Kensler T, Kapita S. Nefazodone and REM sleep: how do antidepressant drugs decrease REM sleep. Sleep 1998;21:70-7.